Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca’s Olaparib Prolongs Remission in Ovarian Cancer
AstraZeneca’s Olaparib Prolongs Remission in Ovarian Cancer
AstraZeneca’s Olaparib Prolongs Remission in Ovarian Cancer
Submitted by
admin
on May 18, 2011 - 6:37pm
Source:
Bloomberg
News Tags:
AstraZeneca
ovarian cancer
olaparib
Headline:
AstraZeneca’s Olaparib Prolongs Remission in Ovarian Cancer
Do Not Allow Advertisers to Use My Personal information
